Elanco Animal Health (ELAN) Non-Current Assets (2017 - 2026)
Elanco Animal Health's (ELAN) quarterly Non-Current Assets came in at $9.8 billion in Q2 2026, down 3.59% year-over-year from $10.1 billion in Q2 2025, and up 1.31% quarter-over-quarter from $9.6 billion in Q1 2026.
Analysis
Elanco Animal Health (ELAN) Non-Current Assets (2017 - 2026) Analysis & Trends
Elanco Animal Health has disclosed Non-Current Assets across 10 years of filings, most recently posting $9.8 billion for Q2 2026.
- In Q2 2026, Non-Current Assets fell 3.59% year-over-year to $9.8 billion; the TTM figure through Jun 2026 stood at $39.4 billion (up 1.07% YoY), while the FY2025 annual figure was $9.9 billion, up 5.33% from the prior year.
- Non-Current Assets came in at $9.8 billion for Q2 2026 at Elanco Animal Health, up from $9.6 billion in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $13.1 billion in Q1 2022 to a low of $9.4 billion in Q4 2024.
- Average Non-Current Assets over 5 years is $10.7 billion, with a median of $10.1 billion recorded in 2025.
- Year-over-year, Non-Current Assets decreased 19.69% in 2024 and grew 5.33% in 2025.
- Over 5 years, Non-Current Assets stood at $12.2 billion in 2022, then slipped by 10.29% to $11.0 billion in 2023, then declined by 14.2% to $9.4 billion in 2024, then increased by 5.33% to $9.9 billion in 2025, then slipped by 1.37% to $9.8 billion in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $9.8 billion in Q2 2026, $9.6 billion in Q1 2026, and $9.9 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.52 Bn | 40.33 Bn | 779.09 Mn | 1.93 Bn |
| 2 | Zoetis | 30.69 Bn | 29.02 Bn | 1.05 Bn | 8.72 Bn |
| 3 | Elanco Animal Health | 11.89 Bn | 11.36 Bn | 798.00 Mn | 9.76 Bn |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | 565.74 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | 25.55 Mn |
| 6 | Zhengye Biotechnology Holding | 75.05 Mn | 67.96 Mn | - | 42.16 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 268,652.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.76 Bn |
| Mar 31, 2026 | 9.64 Bn |
| Dec 31, 2025 | 9.90 Bn |
| Sep 30, 2025 | 10.06 Bn |
| Jun 30, 2025 | 10.13 Bn |
| Mar 31, 2025 | 9.50 Bn |
| Dec 31, 2024 | 9.40 Bn |
| Sep 30, 2024 | 9.92 Bn |
| Jun 30, 2024 | 9.75 Bn |
| Mar 31, 2024 | 9.97 Bn |
| Dec 31, 2023 | 10.96 Bn |
| Sep 30, 2023 | 10.78 Bn |
| Jun 30, 2023 | 12.14 Bn |
| Mar 31, 2023 | 12.22 Bn |
| Dec 31, 2022 | 12.21 Bn |
| Sep 30, 2022 | 11.79 Bn |
| Jun 30, 2022 | 12.29 Bn |
| Mar 31, 2022 | 13.06 Bn |
| Dec 31, 2021 | 13.20 Bn |
| Sep 30, 2021 | 13.41 Bn |